Respective contribution of baseline clinical data, tumour metabolism and tumour blood-flow in predicting pCR after neoadjuvant chemotherapy in HER2 and Triple Negative breast cancer.
Fiche publication
Date publication
juillet 2024
Journal
EJNMMI research
Auteurs
Membres identifiés du Cancéropôle Est :
Pr BRUNOTTE François, Pr COUTANT Charles, Dr LADOIRE Sylvain, Pr COCHET Alexandre, Dr DESMOULINS Isabelle
Tous les auteurs :
Payan N, Presles B, Coutant C, Desmoulins I, Ladoire S, Beltjens F, Brunotte F, Vrigneaud JM, Cochet A
Lien Pubmed
Résumé
The aim of this study is to investigate the added value of combining tumour blood flow (BF) and metabolism parameters, including texture features, with clinical parameters to predict, at baseline, the pathological complete response (pCR) to neoadjuvant chemotherapy (NAC) in patients with newly diagnosed breast cancer (BC).
Mots clés
F-FDG PET/CT, Blood flow, Breast cancer, Pathological Response, Texture Features
Référence
EJNMMI Res. 2024 07 4;14(1):60